Loading...
Chemical structure of PD-1/PD-L1-IN-33

GC26366

PD-1/PD-L1-IN-33

Also known as 2-methyl-2-[[4-(4-phenyl-2,3-dihydroindol-1-yl)pyrido[3,2-d]pyrimidin-7-yl]methylamino]propan-1-ol

PD-1/PD-L1-IN-33 (Compound N11) is a kind of PD-1/PD-L1 inhibitor· PD-1/PD-L1-IN-33 inhibited the interaction between PD-1 and PD-L1, and IC50 was 6·3nM· PD-1/PD-L1-IN-33 promotes the proliferation, activation and infiltration of T cells into tumor balls· PD-1/PD-L1-IN-33 has immunomodulatory and anticancer activities

ChemicalCAS2975602-78-7MW425.53FormulaC26H27N5O
CAS number
2975602-78-7
Molecular weight
425.53
Formula
C26H27N5O
Solubility
DMSO : 100 mg/mL (235·00 mM; ultrasonic and warming and heat to 80°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
InChIKey
CZQOYRCWBPWJJP-UHFFFAOYSA-N
Catalogue number
GC26366
Brand
GLPBIO
Computed properties PubChem CID 168510602 · XLogP 3.5 · TPSA 74.2 Ų · H-bond donors 2
XLogP
3.5
TPSA
74.2 Ų
H-bond donors
2
H-bond acceptors
6
Rotatable bonds
6
Heavy atoms
32

SMILES CC(C)(CO)NCC1=CC2=C(C(=NC=N2)N3CCC4=C(C=CC=C43)C5=CC=CC=C5)N=C1

Computed descriptors from PubChem (CID 168510602), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.